GoT-ChA: A New Tool for Detailing How Gene Mutations Affect Cells
May 8, 2024
A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA. These structural changes, which alter patterns of gene activity in a cell, are known as epigenetic changes and can lead to malignancy.
Daedalus Fund Aims to Advance Translational Studies to Next Stages
April 30, 2024
The Daedalus Fund for Innovation, a unique de-risking program of Weill Cornell Medicine Enterprise Innovation, announced its recipients for funding this year.
Gut Microbiota Acts Like an Auxiliary Liver
April 23, 2024
Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators. The study, published April 23 in Cell Host & Microbe, adds to the growing list of ways in which the microbiome influences physiology, and could lead to new strategies to treat conditions such as inflammatory bowel disease and diabetes.
Tracking a Protein’s Fleeting Shape Changes
April 17, 2024
Researchers at Weill Cornell Medicine have developed a powerful, new technique to generate “movies” of changing protein structures and speeds of up to 50 frames per second.
Researchers Produce Grafts that Replicate the Human Ear
April 1, 2024
Using state-of-the-art tissue engineering techniques and a 3D printer, researchers at Weill Cornell Medicine and Cornell Engineering have assembled a replica of an adult human ear that looks and feels natural. The study, published online in Acta Biomaterialia on March 16, offers the promise of grafts with well-defined anatomy and the correct biomechanical properties for those who are born with a congenital malformation or who lose an ear later in life.
2024 Health Hackathon Yields Innovative Solutions for Enhancing Patient Safety
March 21, 2024
The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.
NSF Awards Grant for Evolution-inspired Design of Therapeutic RNAs
March 19, 2024
A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.
Advancing Neurosurgical Innovations Through Mentor-Mentee Collaborations
March 11, 2024
Dr. Susan Pannullo, professor of clinical neurological surgery, considers it an honor and duty to support the next generation of neurosurgeons and help them reach their personal and professional goals. She met a like-minded mentee, Dr. Mohammed Fouda, fellow in neurological surgery. Both doctors have a keen interest in advancing neurosurgical technologies and team up to improve patient outcomes.
Conference Showcases Biomedical Innovation at the Intersection of Business and Science
March 7, 2024
The 2024 Startup Symposium & InvestConnect Conference celebrated scientific inquiry and the entrepreneurial spirit.
Structural Study Points the Way to Better Malaria Drugs
January 18, 2024
Structural insights into a potent antimalarial drug candidate’s interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers at Weill Cornell Medicine and Van Andel Institute.